Clinical trial
Research for the Molecular Imaging of the HER2 Targeting Tracer
NCT04547309 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Research for the Molecular Imaging of the HER2 Targeting Tracer
- Lead sponsor
- Peking University Cancer Hospital & Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 7, 2020
- Completion date
- August 30, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
her2 positive or suspicious positive tumors